Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001346824-25-000074·Climb Bio, Inc.
Schedule 13D ownership disclosure
Climb Bio, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 28658R106
Event date: 2025-12-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.Reported CIK 0001346824
Shares: 17,953,284.00 · Class: 33.0%
- Peter KolchinskyReported CIK 0001384859
Shares: 17,953,284.00 · Class: 33.0%
- Rajeev ShahReported CIK 0001619841
Shares: 17,953,284.00 · Class: 33.0%
- RA Capital Healthcare Fund, L.P.Reported CIK 0001315082
Shares: 12,485,646.00 · Class: 23.0%
- RA Capital Nexus Fund III, L.P.Reported CIK 0001883840
Shares: 5,346,247.00 · Class: 11.2%
- Sera Medicines, LLC
Shares: 2,479,872.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-25-000074
- Form type
- SCHEDULE 13D/A
- Filer
- Climb Bio, Inc.
- CIK
- CIK 1768446
- Filed
- Dec 15, 2025
- Reporting period
- Dec 11, 2025
- Description
- Schedule 13D beneficial ownership